Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

352 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply to te Brake et al.: Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis.
Velásquez GE, Brooks MB, Coit JM, Sánchez Garavito E, Calderón RI, Jiménez J, Tintaya K, Peloquin CA, Osso E, Lecca L, Davies GR, Mitnick CD. Velásquez GE, et al. Among authors: peloquin ca. Am J Respir Crit Care Med. 2019 May 1;199(9):1167-1168. doi: 10.1164/rccm.201812-2281LE. Am J Respir Crit Care Med. 2019. PMID: 30645140 Free PMC article. No abstract available.
Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial.
Velásquez GE, Brooks MB, Coit JM, Pertinez H, Vargas Vásquez D, Sánchez Garavito E, Calderón RI, Jiménez J, Tintaya K, Peloquin CA, Osso E, Tierney DB, Seung KJ, Lecca L, Davies GR, Mitnick CD. Velásquez GE, et al. Among authors: peloquin ca. Am J Respir Crit Care Med. 2018 Sep 1;198(5):657-666. doi: 10.1164/rccm.201712-2524OC. Am J Respir Crit Care Med. 2018. PMID: 29954183 Free PMC article. Clinical Trial.
The Treatment of Tuberculosis.
Peloquin CA, Davies GR. Peloquin CA, et al. Clin Pharmacol Ther. 2021 Dec;110(6):1455-1466. doi: 10.1002/cpt.2261. Epub 2021 Jun 5. Clin Pharmacol Ther. 2021. PMID: 33837535 Review.
Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis.
Peloquin CA, Velásquez GE, Lecca L, Calderón RI, Coit J, Milstein M, Osso E, Jimenez J, Tintaya K, Sanchez Garavito E, Vargas Vasquez D, Mitnick CD, Davies G. Peloquin CA, et al. Antimicrob Agents Chemother. 2017 Jul 25;61(8):e00038-17. doi: 10.1128/AAC.00038-17. Print 2017 Aug. Antimicrob Agents Chemother. 2017. PMID: 28559269 Free PMC article. Clinical Trial.
Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial.
Milstein M, Lecca L, Peloquin C, Mitchison D, Seung K, Pagano M, Coleman D, Osso E, Coit J, Vargas Vasquez DE, Sanchez Garavito E, Calderon R, Contreras C, Davies G, Mitnick CD. Milstein M, et al. BMC Infect Dis. 2016 Aug 27;16(1):453. doi: 10.1186/s12879-016-1790-x. BMC Infect Dis. 2016. PMID: 27567500 Free PMC article.
Erratum for Peloquin et al., "Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis".
Peloquin CA, Velásquez GE, Lecca L, Calderón RI, Coit J, Milstein M, Osso E, Jimenez J, Tintaya K, Garavito ES, Vasquez DV, Mitnick CD, Davies G. Peloquin CA, et al. Antimicrob Agents Chemother. 2017 Aug 24;61(9):e01524-17. doi: 10.1128/AAC.01524-17. Print 2017 Sep. Antimicrob Agents Chemother. 2017. PMID: 28839086 Free PMC article. No abstract available.
Tuberculosis pharmacotherapy: strategies to optimize patient care.
Mitnick CD, McGee B, Peloquin CA. Mitnick CD, et al. Among authors: peloquin ca. Expert Opin Pharmacother. 2009 Feb;10(3):381-401. doi: 10.1517/14656560802694564. Expert Opin Pharmacother. 2009. PMID: 19191677 Free PMC article. Review.
An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial.
Bouton TC, Phillips PPJ, Mitnick CD, Peloquin CA, Eisenach K, Patientia RF, Lecca L, Gotuzzo E, Gandhi NR, Butler D, Diacon AH, Martel B, Santillan J, Hunt KR, Vargas D, von Groote-Bidlingmaier F, Seas C, Dianis N, Moreno-Martinez A, Horsburgh CR Jr. Bouton TC, et al. Among authors: peloquin ca. Trials. 2017 Nov 25;18(1):563. doi: 10.1186/s13063-017-2292-x. Trials. 2017. PMID: 29178937 Free PMC article. Clinical Trial.
Increased Doses Lead to Higher Drug Exposures of Levofloxacin for Treatment of Tuberculosis.
Peloquin CA, Phillips PPJ, Mitnick CD, Eisenach K, Patientia RF, Lecca L, Gotuzzo E, Gandhi NR, Butler D, Diacon AH, Martel B, Santillan J, Hunt KR, Vargas D, von Groote-Bidlingmaier F, Seas C, Dianis N, Moreno-Martinez A, Kaur P, Horsburgh CR Jr. Peloquin CA, et al. Antimicrob Agents Chemother. 2018 Sep 24;62(10):e00770-18. doi: 10.1128/AAC.00770-18. Print 2018 Oct. Antimicrob Agents Chemother. 2018. PMID: 30012767 Free PMC article. Clinical Trial.
352 results